Development of ifosfamide-induced nephrotoxicity: Prospective follow-up in 75 patients

Medical and Pediatric Oncology

Volumn 32, Issue 3, 1999, Pages 177-182

  Rossi, Rainer ^a   Pleyer, Julia ^a   Schäfers, Petra ^a   Kuhn, Nanna ^a   Kleta, Robert ^a   Deufel, Thomas ^a   Jürgens, Heribert ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Padiatrische Hamatologie/Onkologie   (Germany)

Author keywords

Cytostatic treatment; Ifosfamide; Nephrotoxicity; Renal Fanconi syndrome; Renal proximal tubule

Indexed keywords

CISPLATIN; GENTAMICIN; IFOSFAMIDE; MESNA; METHOTREXATE;

AMINOACIDURIA; ARTICLE; CHILD; CYTOSTASIS; DRUG EFFECT; DRUG INDUCED DISEASE; FANCONI RENOTUBULAR SYNDROME; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; FANCONI SYNDROME; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INFANT; INFANT, NEWBORN; KIDNEY GLOMERULUS; KIDNEY TUBULES; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0033049763     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H     Document Type: Article

References (25)

1. Pratt CB, Meyer WH, Jenkins JJ, et al. Ifosfamide, Fanconi's syndrome, and rickets. J Clin Oncol 1991;9:1495-1499.
2. Suarez A, McDowell H, Niaudet P, et al. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report. J Clin Oncol 1991;9:2177-2182.
3. Rossi R, Gödde A, Kleinebrand A, et al. Unilateral nephrectomy and cisplatinum as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 1994;12:159-165.
4. Moncrieff M, Foot A. Fanconi syndrome after ifosfamide. Cancer Chemother Pharmacol 1989;23:121-122.
5. Heney D, Lewis IJ, Bailey CC. Acute ifosfamide-induced tubular toxicity [letter]. Lancet 1989;II:103-104.
6. van Gool S, Brock P, Wijndaele G, et al. Reversible hypophosphataemic rickets following ifosfamide treatment. Med Pediatr Oncol 1992;20:254-257.
7. Skinner R, Pearson ADJ, English MW, et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996;348:578-580.
8. Caron HN, Abeling N, van Gennip A, et al. Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimes. Med Pediatr Oncol 1992;20:42-47.
9. Burk CD, Restaino I, Kaplan BS, et al. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor. J Pediatr 1990;117:331-335.
10. Rossi R, Kleinebrand A, Gödde A, et al. Increased risk of ifosfamide-induced renal Fanconi's syndrome after unilateral nephrectomy (letter to the editor). Lancet 1993;341:755.
11. Ashraf MS, Brady J, Breatnach F, et al. Ifosfamide nephrotoxicity in paediatric cancer patients. Eur J Pediatr 1994;153:90-94.
12. Skinner R, Pearson ADJ, Price L, et al. Nephrotoxicity after ifosfamide. Arch Dis Child 1990;65:732-738.
13. Goren MP, Pratt CB, Viar MJ. Tubular nephrotoxicity during long-term ifosfamide and mesna therapy. Cancer Chemother Pharmacol 1989;25:70-72.
14. von der Hardt K, Zimmerhackl LB, de Broe ME, et al. Indicators of acute nephrotoxicity during non-cisplatinum chemotherapy in childhood. Int J Pediatr Hematol Oncol 1997;4:107-119.
15. Ho PTC, Zimmermann KRN, Wexler LH, et al. A prospective evaluation of ifosfamide-related nephrotoxicity in children and adults. Cancer 1995;76:2557-2564.
16. Heney D, Wheeldon J, Rushworth P, et al. Progressive renal toxicity due to ifosfamide. Arch Dis Child 1991;66:966-970.
17. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-590.
18. Rossi R, Danzebrink S, Linnenbürger K, et al. Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples. Acta Paediatr 1994;83:1282-1286.
19. Brodehl J. The Fanconi syndrome. In: Edelmann CM, editor. Pediatric kidney disease. Boston: Little, Brown and Company; 1992. p 1841-1871.
20. Hostetter TH, Rennke HG, Brenner BM. Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. Am J Kidney Dis 1982;1:310-314.
21. Luder J, Sheldon W. A familial tubular absorption defect of glucose and amino acids. Arch Dis Child 1955;30:160-164.
22. Patrick A, Cameron JS, Ogg CS. A family with a dominant form of idiopathic Fanconi syndrome leading to renal failure in adult life. Clin Nephrol 1981;16:289-292.
23. Mohrmann M, Ansorge S, Schmich U. et al. Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr Nephrol 1994;8:157-163.
24. Lauterburg B, Nguyen T, Hartmann B, et al. Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/ mesna therapy. Cancer Chemother Pharmacol 1994;35:132-136.
25. Rossi R. Nephrotoxicity of ifosfamide - moving towards understanding the molecular mechanisms. Nephrol Dial Transplant 1997;12:1091-1092.